Resveratrol sensitizes breast cancer to PARP inhibitor, talazoparib through dual inhibition of AKT and autophagy flux
Ganesh Pai Bellare, Birija Sankar Patro
Topics & Concepts
ResveratrolCancer researchAutophagyPARP1PI3K/AKT/mTOR pathwayCancer cellCancerBreast cancerChemistryProgrammed cell deathProtein kinase BBiologyPoly ADP ribose polymerasePharmacologyCell biologyApoptosisSignal transductionBiochemistryPolymeraseGeneGeneticsPARP inhibition in cancer therapySirtuins and Resveratrol in MedicineCalcium signaling and nucleotide metabolism